Excellent Research Against Diabetes
Diabetes research: At this year's congress of the European Association for the Study of Diabetes (EASD), Helmholtz Munich scientists received several awards for pioneering ideas and ways to fight the disease.
For the discovery of a whole series of new drugs, the scientific director and CEO of Helmholtz Munich, Matthias H. Tschöp, received the EASD-Lilly Centennial Anniversary Prize 2022.
Anette-Gabriele Ziegler, Director of the Helmholtz Munich Institute for Diabetes Research (IDF) was honored with the EASD-Novo Nordisk Foundation Diabetes Prize for Excellence 2022.
Alexander Jais, Junior Research Group Leader ‘Diet-Induced Metabolic Alterations’ at the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) in Leipzig, also received a highly endowed award: the Future Leader Award of the European Foundation for the Study of Diabetes (EFSD)/Novo Nordisk Foundation.
Read more at the Helmholtz Website